异形性肺纤维化的非药理学管理
Jon B Mullholand1, Catherine E Grossman1, Apostolos Perelas1
1Division of Pulmonary Disease and Critical Care Medicine, Virginia Commonwealth University, Richmond, VA 23298, USA.
Journal of clinical medicine
|February 26, 2025
概括
非药物疗法为异常性肺纤维化 (IPF) 患者提供了显著的好处,改善了生活质量和症状. 这些包括补充氧气,肺部康复和睡眠优化,补充医疗治疗.
科学领域:
- 肺部病理学 肺部病理学
- 间歇性肺病 间歇性肺病
- 纤维化肺部疾病 纤维化肺部疾病
背景情况:
- 异形性肺纤维化 (IPF) 是一种进展性,致命的肺病,治疗选择有限.
- 目前的药物只能减缓疾病的进展;肺移植是唯一的治疗方法.
- 非药物治疗对于控制症状和改善IPF患者的生活质量至关重要.
研究的目的:
- 审查非药物干预措施在治疗异常性肺纤维化症中的作用和影响.
- 突出治疗方法,可以改善患者的结果和生活质量,并与医疗治疗.
主要方法:
- 对IPF的非药物治疗方法的当前文献的综述.
- 分析支持干预措施的证据,如补充氧气,肺部康复,睡眠优化和营养支持.
- 讨论每个治疗方法的好处和局限性.
主要成果:
- 补充氧气可以提高运动能力,并减少缺血性IPF患者的呼吸障碍.
- 肺部康复显著提高患者的耐力和力量,尽管可用性是一个挑战.
- 优化睡眠,反流控制,营养和息护理是症状管理的重要辅助.
结论:
- 非药物疗法是全面IPF护理的重要组成部分,改善生活质量和症状负担.
- 建议进一步研究睡眠优化和更广泛地采用肺部康复.
- 综合护理包括营养,息疗法和及时肺移植评估对于IPF管理至关重要.
相关概念视频
01:29Chronic Obstructive Pulmonary Disease-V: Management
2.5K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
2.5K
01:26COPD: Management Using Bronchodilators and Corticosteroids
170
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
170
01:24Cystic Fibrosis: Management
136
Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...
Sinus disease and chronic...
136
01:20Chronic Obstructive Pulmonary Disease-I: Introduction
2.7K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
2.7K
01:30Pneumonia V: Nursing management and Prevention
1.8K
Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
1.8K
01:17Drugs Used in Lower Respiratory Disorders: Overview
335
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
335